Xichun Hu

Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer

Aditya Bardia, Xichun Hu, Rebecca Dent et al. · New England Journal of Medicine · 2024 · 297 citations

Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study

Jie Xie, Jun Cao, Jingfen Wang et al. · Breast Cancer Research and Treatment · 2017 · 33 citations

Breast Oncology, Breast Cancer Patients, Medicine +6

Efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial

Fengrui Xu, Yang Zhang, Zhanhui Miao et al. · Annals of Translational Medicine · 2019 · 33 citations · Full text

Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy—a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelines

Shiying Yu, Thomas Burke, Alexandre Chan et al. · Supportive Care in Cancer · 2014 · 30 citations

Medicine, Cancer Management, Metronomic Therapy +7

A randomized multicenter phase II trial of mecapegfilgrastim single administration versus granulocyte colony-stimulating growth factor on treating chemotherapy-induced neutropenia in breast cancer patients

Tao Wang, Biao Wu, Xichun Hu et al. · Annals of Translational Medicine · 2019 · 19 citations · Full text